Saturday, September 5, 2009

Mesothelioma Life Expectancy

Mesothelioma life expectancy at the time of diagnosis will
traditionally be announced at being somewhere between a few months to
only a year or two. Statistically speaking, mesothelioma life
expectancy is frighteningly short. However, the mesothelioma life
expectancy rate is a mere average, mean or median of mesothelioma
patients with wildly different independent variables. Many of these
mesothelioma patients have lived years past their expected "date of
death" estimate.Mesothelioma treatment and mesothelioma treatment
options for these patients differed. Physicians for some patients may
have been more experienced than physicians for the less fortunate. Not
all patients follow through with chemotherapy or cancer treatment
plans upon hearing the low mesothelioma life expectancy statistics,
and many are not in shape to handle surgery. Others fight to live for
just one more day.

Survival stories that can affect mesothelioma life expectancy rates
range from the rarer cases of a young woman being "cured" – or having
no remittance for decades, to the extremes on the other side, an 80+
year old gentleman with lifetime asbestos exposure, smoking heavily
and suffering from numerous pre-existing diseases who dies a month
after diagnosis. Others die during surgery. Most mesothelioma patient
circumstances are somewhere in between. Many mesothelioma sufferers
and their life expectancy statistics go unrecorded. Mesothelioma life
expectancy will depend on your individual variables, your medical
treatment, and your perseverance and outlook.

Mesothelioma life expectancy diagnosis will always depend on how early
or late the disease was discovered. Because mesothelioma has been
largely unrecognized in the past, the bulk of mesothelioma life
expectancy statistics are mesothelioma patients who were diagnosed
late in the disease. A greater awareness of the disease exists in the
medical community, and although the majority of physicians do not have
experience treating mesothelioma, most are aware of the potential
presence of mesothelioma if a patient has been exposed to asbestos,
and can refer a potential mesothelioma patient to a specialist.

Early detection and early treatment leads to longer life expectancy.
Individuals who have been exposed to asbestos can be pro-active in
diagnosing and treating mesothelioma and other asbestos-caused
diseases. Patients can monitor their health and mesothelioma symptoms
and begin early detection X-ray and CT scan tests. Mesothelioma
patients can research mesothelioma treatment options available in
clinical trials and discuss these with their physician. A physician
can not be aware of every clinical trial that exists, and a
mesothelioma patient's own research could add years on to mesothelioma
life expectancy.

Statistics for mesothelioma life expectancy will logically improve
rather than become worse. Clinical trials on mesothelioma treatment
options are increasing with an urgency to halt the disease. Many
clinical trial participants live years past the initial diagnosis due
to innovative mesothelioma treatment. Others may have participated in
a mesothelioma clinical trial that was not as successful, but their
participation has cleared the way to successful mesothelioma treatment
for others. Chemotherapy and drug combinations have been proven to
lengthen mesothelioma life expectancy. Imaging and radiation
technology has made significant advances.

Mesothelioma life expectancy can pass the low mesothelioma life
expectancy rates of the past. Nobody in the statistics of mesothelioma
has the identical combination of the physical, emotional, and
environmental variables that you do. Medicine advances, it does not go
backwards. Mesothelioma treatment and mesothelioma treatment options
for your early stage or advanced malignant stage mesothelioma will be
up to you. There is a strong chance that you can defy mesothelioma
life expectancy statistics. Research. Stay alert to new mesothelioma
treatment options. And look at yourself, not statistics.

No comments:

Post a Comment